In an August 2023 interview with BioSpace , Michael Glickman said that in his experience patients who were on GLP-1 medicines reported a weaker desire to smoke or drink after initiation
Comparing Mounjaro to Other GLP-1 Treatments When comparing Mounjaro to established GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy) , dulaglutide (Trulicity) , and liraglutide (Victoza, Saxenda) , several key differences emerge
There was also a decrease in the biomarkers for oxidative stress and an improvement in immune markers
Stacked together, they amplify your natural GH output to support fat metabolism, lean tissue preservation, and overnight recovery simultaneously
The study had certain criteria that excluded individuals who had severe liver or renal impairment (defined as serum alanine transaminase (ALT) 3-fold the upper limit of normal